For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...
News Medical on MSN19h
Leveling up NGS workflows with INTEGRA Biosciences’ solutionsINTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation ...
Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...
Regeneron and Illumina have joined a major investment ... drug discovery and transform patient care." After the initial sequencing, the biospecimens will be stored to support future multi-omics ...
It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the structure and function of genomes. A study involving 14% of the people in Greenland ...
Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to complement next-generation sequencing (NGS) for precise patient ...
After hours: February 12 at 5:46:15 PM EST Loading Chart for NGS ...
Analysis pipeline to detect germline or somatic variants (pre-processing, variant calling and annotation) from WGS / targeted sequencing ...
Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback